Ex vivo expansion of the highly cytotoxic human natural killer-92 cell-line under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy

By Tam Yk   Martinson Ja   Doligosa K   Klingemann H-g  

Cytotherapy, Vol. 5, Iss. 3, 2003-01 ,pp. : 259-272

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer

By Junker Niels   Andersen Mads Hald   Wenandy Lynn   Dombernowsky Sarah Louise   Kiss Katalin   Sørensen Christian Hjort   Therkildsen Marianne Hamilton   Von Buchwald Christian   Andersen Elo   Straten Per Thor   Svane Inge Marie  

Cytotherapy, Vol. 13, Iss. 7, 2011-08 ,pp. : 822-834

Ashgate Publishing Ltd

Access to resources Recommend Favorite

GMP production of anti-tumor cytotoxic T-cell lines for adoptive T-cell therapy in patients with solid neoplasia

By Turin I.   Pedrazzoli P.   Tullio C.   Montini E.   La Grotteria M Carmela   Schiavo R.   Perotti C.   Locatelli F.   Carretto E.   Maccario R.   Siena S.   Montagna D.  

Cytotherapy, Vol. 9, Iss. 5, 2007-01 ,pp. : 499-507

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Zoledronate facilitates large-scale ex vivo expansion of functional γδ T cells from cancer patients for use in adoptive immunotherapy

By Kondo M.   Sakuta K.   Noguchi A.   Ariyoshi N.   Sato K.   Sato S.   Sato K.   Hosoi A.   Nakajima J.   Yoshida Y.   Shiraishi K.   Nakagawa K.   Kakimi K.  

Cytotherapy, Vol. 10, Iss. 8, 2008-01 ,pp. : 842-856

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Ex vivo expansion of non-MHC-restricted cytotoxic effector cells as adoptive immunotherapy for myeloma

By Wu Jy   Ernstoff Ms   Hill Jm   Cole B   Meehan Kr  

Cytotherapy, Vol. 8, Iss. 2, 2006-05 ,pp. : 141-148

Ashgate Publishing Ltd

Access to resources Recommend Favorite